The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, January 16, 2020,Sopharma AD notifies that the Company will initiate gross dividend payment of the voted on the EGM held on December 13, 2019 dividend of 0.05 BGN per share on January 22, 2020.
Sofia, Bulgaria, January 10, 2020 - Sopharma AD notifies that for December 2019 the Company recorded an increase in sales of 16% compared to the same month of 2018, incl. 5% increase in sales for the domestic market and 27% increase in export sales.
In 2019 the revenues from sales of production increased by 9% compared to the same period of 2018, incl. keeping sales in domestic market and 15% increase in export sales.
Sofia, Bulgaria, December 20, 2019 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on December 19, 2019 the Company bought 2 000 own shares representing 0.0015% of the share capital of the Company, at a total value of 6 890 BGN on the Bulgarian Stock Exchange, the average price per share was 3.4450 BGN.
The total number of treasury shares after this transaction is 9 112 667, representing 6.76% of the share capital of the Company.